Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In
Clinical trial NCT02708680 · COMPLETED
Trial details
- NCT number
- NCT02708680
- Sponsor
- Syndax Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2021-03-31
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.